CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase 2 Trial of Menin Inhibitor BN104 as Post Hematopoietic Stem Cell Transplantation Maintenance in Patients With Acute Leukemia
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT07101497
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:30.921885+00:00
- Published At
- 2025-08-03T00:00:00+00:00
- Record Updated At
- 2025-08-03
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Menin Inhibitors", "Post Hematopoietic Stem Cell Transplantation", "Maintenance Therapy", "Acute Leukemia", "KMT2A Rearrangement", "NPM1 Mutation", "NUP98 Gene Rearrangement"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-08-03"- protocolSection.identificationModule.nctId
"NCT07101497"- protocolSection.identificationModule.officialTitle
"Phase 2 Trial of Menin Inhibitor BN104 as Post Hematopoietic Stem Cell Transplantation Maintenance in Patients With Acute Leukemia"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.